KYVERNA THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. - KYTX
Portfolio Pulse from
Kahn Swick & Foti, LLC has issued a reminder for investors with significant losses to file lead plaintiff applications by February 7, 2025, in a class action lawsuit against Kyverna Therapeutics, Inc. The lawsuit pertains to shares purchased in connection with Kyverna's February 2024 IPO.
January 22, 2025 | 4:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Kyverna Therapeutics is facing a class action lawsuit related to its February 2024 IPO. Investors with losses exceeding $100,000 are reminded to file lead plaintiff applications by February 7, 2025.
The class action lawsuit against Kyverna Therapeutics is likely to negatively impact its stock price in the short term due to potential legal liabilities and investor concerns. The deadline for lead plaintiff applications is February 7, 2025, which may increase selling pressure as investors react to the news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100